Status:
UNKNOWN
Antihypertensive Therapy in Patients With Comorbidities
Lead Sponsor:
Center of Personalized Medicine, Pirogova
Collaborating Sponsors:
Center for New Medical Technologies, Novosibirsk, Russia
I.M. Sechenov First Moscow State Medical University
Conditions:
Adherence to Personalized EBM Antihypertensive Drug Prescriptions for Patients With Hypertension and Comorbidities in Everyday Clinical Practice
Eligibility:
All Genders
18+ years
Brief Summary
A retrospective analysis
Detailed Description
This retrospective study will be performed using all-Russian nationwide database of anonymized medical health claims and administrative data. The database holds information on diagnoses, patient data,...
Eligibility Criteria
Inclusion
- patients who were first diagnosed with hypertension, attended the hospital as an outpatient due to hypertension, and received their antihypertensive prescription as an outpatient. To be eligible for inclusion, patients had to have comorbidities and outpatient visits or hospitalizations (for any indication) during the 3-years.
Exclusion
- No
Key Trial Info
Start Date :
February 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 30 2021
Estimated Enrollment :
100000 Patients enrolled
Trial Details
Trial ID
NCT04791046
Start Date
February 1 2021
End Date
March 30 2021
Last Update
March 11 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Evgeny Pokushalov
Novosibirsk, Russia, 630090